227 related articles for article (PubMed ID: 19818564)
1. Epigenetics: origins and implications for cancer epidemiology.
Nise MS; Falaturi P; Erren TC
Med Hypotheses; 2010 Feb; 74(2):377-82. PubMed ID: 19818564
[TBL] [Abstract][Full Text] [Related]
2. Epigenetics and cancer: towards an evaluation of the impact of environmental and dietary factors.
Herceg Z
Mutagenesis; 2007 Mar; 22(2):91-103. PubMed ID: 17284773
[TBL] [Abstract][Full Text] [Related]
3. Computational epigenetics.
Bock C; Lengauer T
Bioinformatics; 2008 Jan; 24(1):1-10. PubMed ID: 18024971
[TBL] [Abstract][Full Text] [Related]
4. Epigenetics: molecular mechanisms and implications for disease.
Handel AE; Ebers GC; Ramagopalan SV
Trends Mol Med; 2010 Jan; 16(1):7-16. PubMed ID: 20022812
[TBL] [Abstract][Full Text] [Related]
5. Introduction: epigenetics and cancer.
Herceg Z; Ushijima T
Adv Genet; 2010; 70():1-23. PubMed ID: 20920743
[TBL] [Abstract][Full Text] [Related]
6. A new paradigm in toxicology and teratology: altering gene activity in the absence of DNA sequence variation.
Reamon-Buettner SM; Borlak J
Reprod Toxicol; 2007 Jul; 24(1):20-30. PubMed ID: 17596910
[TBL] [Abstract][Full Text] [Related]
7. Epigenetics in molecular epidemiology of cancer a new scope.
Yuasa Y
Adv Genet; 2010; 71():211-35. PubMed ID: 20933130
[TBL] [Abstract][Full Text] [Related]
8. Methods in cancer epigenetics and epidemiology.
Kumar D; Verma M
Methods Mol Biol; 2009; 471():273-88. PubMed ID: 19109785
[TBL] [Abstract][Full Text] [Related]
9. The next innovation cycle in toxicogenomics: environmental epigenetics.
Reamon-Buettner SM; Mutschler V; Borlak J
Mutat Res; 2008; 659(1-2):158-65. PubMed ID: 18342568
[TBL] [Abstract][Full Text] [Related]
10. Recursive causality in evolution: a model for epigenetic mechanisms in cancer development.
Haslberger A; Varga F; Karlic H
Med Hypotheses; 2006; 67(6):1448-54. PubMed ID: 16844314
[TBL] [Abstract][Full Text] [Related]
11. Epigenetic signatures in cancer: Implications for the control of cancer in the clinic.
Lima SC; Hernandez-Vargas H; Herceg Z
Curr Opin Mol Ther; 2010 Jun; 12(3):316-24. PubMed ID: 20521220
[TBL] [Abstract][Full Text] [Related]
12. American Society of Clinical Oncology policy statement update: genetic testing for cancer susceptibility.
American Society of Clinical Oncology
J Clin Oncol; 2003 Jun; 21(12):2397-406. PubMed ID: 12692171
[TBL] [Abstract][Full Text] [Related]
13. Cancer susceptibility: epigenetic manifestation of environmental exposures.
Weidman JR; Dolinoy DC; Murphy SK; Jirtle RL
Cancer J; 2007; 13(1):9-16. PubMed ID: 17464241
[TBL] [Abstract][Full Text] [Related]
14. Epigenetic targets in cancer epidemiology.
Dumitrescu RG
Methods Mol Biol; 2009; 471():457-67. PubMed ID: 19109794
[TBL] [Abstract][Full Text] [Related]
15. Epigenetics and cancer: implications for drug discovery and safety assessment.
Moggs JG; Goodman JI; Trosko JE; Roberts RA
Toxicol Appl Pharmacol; 2004 May; 196(3):422-30. PubMed ID: 15094313
[TBL] [Abstract][Full Text] [Related]
16. Epigenetics of endometriosis.
Guo SW
Mol Hum Reprod; 2009 Oct; 15(10):587-607. PubMed ID: 19651637
[TBL] [Abstract][Full Text] [Related]
17. Systems epidemiology in cancer.
Lund E; Dumeaux V
Cancer Epidemiol Biomarkers Prev; 2008 Nov; 17(11):2954-7. PubMed ID: 18990736
[TBL] [Abstract][Full Text] [Related]
18. Global epigenetic screening technologies: a novel tool to address cancer health disparities in high-risk population groups.
Guerrero-Preston R
P R Health Sci J; 2008 Dec; 27(4):350-6. PubMed ID: 19069364
[TBL] [Abstract][Full Text] [Related]
19. Epigenetic biomarkers in cancer epidemiology.
Verma M
Methods Mol Biol; 2012; 863():467-80. PubMed ID: 22359311
[TBL] [Abstract][Full Text] [Related]
20. [Genetic epidemiology and cancer].
Olsen JH; Hahnemann JM; Brøndum-Nielsen K
Ugeskr Laeger; 2006 Jun; 168(24):2344-8. PubMed ID: 16822417
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
